![Halofuginone inhibition of COL1A2 promoter activity via a c‐Jun–dependent mechanism - McGaha - 2002 - Arthritis & Rheumatism - Wiley Online Library Halofuginone inhibition of COL1A2 promoter activity via a c‐Jun–dependent mechanism - McGaha - 2002 - Arthritis & Rheumatism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/612f8d44-2e59-43a1-8324-a355d34cc65b/mfig005.jpg)
Halofuginone inhibition of COL1A2 promoter activity via a c‐Jun–dependent mechanism - McGaha - 2002 - Arthritis & Rheumatism - Wiley Online Library
![7 Leberzirrhose. Ausgewählte klinische, therapeutische und sozialmedizinische Fragen. Unternehmensgruppe Dr. Marx Schriften zur Rehabilitation - PDF Free Download 7 Leberzirrhose. Ausgewählte klinische, therapeutische und sozialmedizinische Fragen. Unternehmensgruppe Dr. Marx Schriften zur Rehabilitation - PDF Free Download](https://docplayer.org/docs-images/49/19862322/images/page_16.jpg)
7 Leberzirrhose. Ausgewählte klinische, therapeutische und sozialmedizinische Fragen. Unternehmensgruppe Dr. Marx Schriften zur Rehabilitation - PDF Free Download
![Halofuginone inhibition of COL1A2 promoter activity via a c‐Jun–dependent mechanism - McGaha - 2002 - Arthritis & Rheumatism - Wiley Online Library Halofuginone inhibition of COL1A2 promoter activity via a c‐Jun–dependent mechanism - McGaha - 2002 - Arthritis & Rheumatism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/44fae3aa-5ad7-4fc2-a86d-d1c16448647e/mfig004.jpg)
Halofuginone inhibition of COL1A2 promoter activity via a c‐Jun–dependent mechanism - McGaha - 2002 - Arthritis & Rheumatism - Wiley Online Library
![Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours - European Journal of Cancer Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e1398fc5-27da-46f8-846d-73e46828eea3/gr2.jpg)
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours - European Journal of Cancer
![IJMS | Free Full-Text | The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment | HTML IJMS | Free Full-Text | The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment | HTML](https://www.mdpi.com/ijms/ijms-23-01351/article_deploy/html/images/ijms-23-01351-g001.png)